Document is current
Any future updates will be listed below
-
Authors
Cullis, P. R. https://orcid.org/0000-0001-9586-2508
Felgner, P. L. https://orcid.org/0000-0002-4117-8505
- License Information
-
More Information
Article History
Accepted: 17 May 2024
First Online: 4 July 2024
Competing interests
: P.R.C. has financial interests in Acuitas Therapeutics, Integrated NanoTherapeutics and NanoVation Therapeutics. He is Chair of NanoVation. PLF has financial interests in Gene Therapy Systems, Antigen Discovery Inc. and SeroSight.
